Microcytic anemia: Pathology review

19,551views

Microcytic anemia: Pathology review

Exam2

Exam2

Cushing syndrome
Pheochromocytoma
Congenital adrenal hyperplasia
Primary adrenal insufficiency
Waterhouse-Friderichsen syndrome
Hyperaldosteronism
Adrenal cortical carcinoma
Conn syndrome
Thyroglossal duct cyst
Hyperthyroidism
Graves disease
Thyroid eye disease (NORD)
Toxic multinodular goiter
Thyroid storm
Hypothyroidism
Euthyroid sick syndrome
Hashimoto thyroiditis
Subacute granulomatous thyroiditis
Riedel thyroiditis
Thyroid cancer
Hyperparathyroidism
Hypoparathyroidism
Hypercalcemia
Hypocalcemia
Diabetes mellitus
Diabetic retinopathy
Diabetic nephropathy
Hyperpituitarism
Pituitary adenoma
Hyperprolactinemia
Prolactinoma
Gigantism
Acromegaly
Hypopituitarism
Pituitary apoplexy
Sheehan syndrome
Hypoprolactinemia
Constitutional growth delay
Diabetes insipidus
Syndrome of inappropriate antidiuretic hormone secretion (SIADH)
Multiple endocrine neoplasia
Pancreatic neuroendocrine neoplasms
Zollinger-Ellison syndrome
Carcinoid syndrome
Neuroblastoma
Opsoclonus myoclonus syndrome (NORD)
Adrenal insufficiency: Pathology review
Adrenal masses: Pathology review
Hyperthyroidism: Pathology review
Hypothyroidism: Pathology review
Thyroid nodules and thyroid cancer: Pathology review
Parathyroid disorders and calcium imbalance: Pathology review
Diabetes mellitus: Pathology review
Cushing syndrome and Cushing disease: Pathology review
Pituitary tumors: Pathology review
Hypopituitarism: Pathology review
Diabetes insipidus and SIADH: Pathology review
Multiple endocrine neoplasia: Pathology review
Iron deficiency anemia
Beta-thalassemia
Alpha-thalassemia
Sideroblastic anemia
Anemia of chronic disease
Lead poisoning
Hemolytic disease of the newborn
Glucose-6-phosphate dehydrogenase (G6PD) deficiency
Autoimmune hemolytic anemia
Pyruvate kinase deficiency
Paroxysmal nocturnal hemoglobinuria
Sickle cell disease (NORD)
Hereditary spherocytosis
Aplastic anemia
Fanconi anemia
Megaloblastic anemia
Folate (Vitamin B9) deficiency
Vitamin B12 deficiency
Diamond-Blackfan anemia
Acute intermittent porphyria
Porphyria cutanea tarda
Hemophilia
Vitamin K deficiency
Bernard-Soulier syndrome
Glanzmann's thrombasthenia
Hemolytic-uremic syndrome
Thrombotic thrombocytopenic purpura
Von Willebrand disease
Disseminated intravascular coagulation
Heparin-induced thrombocytopenia
Antithrombin III deficiency
Factor V Leiden
Protein C deficiency
Protein S deficiency
Antiphospholipid syndrome
Hodgkin lymphoma
Non-Hodgkin lymphoma
Microcytic anemia: Pathology review
Non-hemolytic normocytic anemia: Pathology review
Intrinsic hemolytic normocytic anemia: Pathology review
Extrinsic hemolytic normocytic anemia: Pathology review
Macrocytic anemia: Pathology review
Heme synthesis disorders: Pathology review
Coagulation disorders: Pathology review
Platelet disorders: Pathology review
Mixed platelet and coagulation disorders: Pathology review
Thrombosis syndromes (hypercoagulability): Pathology review
Lymphomas: Pathology review
Leukemias: Pathology review
Plasma cell disorders: Pathology review
Myeloproliferative disorders: Pathology review
Type I hypersensitivity
Food allergy
Anaphylaxis
Asthma
Type II hypersensitivity
Rheumatic heart disease
Myasthenia gravis
Pemphigus vulgaris
Type III hypersensitivity
Serum sickness
Systemic lupus erythematosus
Poststreptococcal glomerulonephritis
Type IV hypersensitivity
Graft-versus-host disease
Contact dermatitis
X-linked agammaglobulinemia
Selective immunoglobulin A deficiency
Common variable immunodeficiency
IgG subclass deficiency
Hyperimmunoglobulin E syndrome
Isolated primary immunoglobulin M deficiency
Thymic aplasia
DiGeorge syndrome
Severe combined immunodeficiency
Adenosine deaminase deficiency
Ataxia-telangiectasia
Hyper IgM syndrome
Wiskott-Aldrich syndrome
Leukocyte adhesion deficiency
Chediak-Higashi syndrome
Chronic granulomatous disease
Complement deficiency
Hereditary angioedema
Asplenia
Thymoma
Ruptured spleen
Immunodeficiencies: T-cell and B-cell disorders: Pathology review
Immunodeficiencies: Combined T-cell and B-cell disorders: Pathology review
Immunodeficiencies: Phagocyte and complement dysfunction: Pathology review

Questions

USMLE® Step 1 style questions USMLE

0 of 8 complete

Start
A 6-year-old boy is brought to the pediatrics PA by his parent, who states the patient has been lethargic for the past several weeks. The patient is in the 30th percentile for height and weight and has no significant past medical history. He has no abnormal bleeding, recent infections, or loss of sensation in the limbs. Temperature is 37.0°C (98.6°F), pulse is 96/min, respirations are 17/min, and blood pressure is 114/68 mmHg. Physical examination shows conjunctival pallor. Laboratory studies are as follows:  

 Laboratory Value  Result  Reference Range 
 Hemoglobin  9.8 g/dL  13.5-17.5 g/dL 
 Mean corpuscular volume  78 fL  80-100 fL 
 Reticulocyte count  0.5%  0.5-1.5% 
 Serum iron  45 μg/dL  50-170 μg/dL 
 Ferritin  180 ng/mL  15-200 ng/mL 
 Lead  1 μg/dL (Normal < 5)  <5 μg/dL 
   
Bone marrow aspirate with Prussian blue stain reveals ringed, immature red blood cells, as demonstrated below:

Image reproduced from Wikimedia Commons


 Treatment with which of the following is most likely to improve this patient’s condition? 

Transcript

Watch video only

At the family medicine center, there is a 60-year-old Indigenous American named Istu who came to visit the doctor because of his progressive fatigue and difficulty in swallowing. Next to him, there is a mother from Greece with her child, Thalia, who is 10 months old. Little Thalia appeared healthy at birth but in the past 2 months, her mother noticed that her face was often pale, she’s been less active, and there was a mass in her belly.

Both Istu and Thalia are suffering from anemia, which is defined as lower than average levels of hemoglobin, typically below 13.5 g/dL in adult men and below 12.0 g/dL in adult women. For children, this level varies based on the age. Now, anemias can be broadly grouped into 3 categories based on mean corpuscular volume, or MCV, which reflects the volume of a Red blood cell or RBC. So microcytic anemia is where the MCV is lower than 80 fL, normocytic, with an MCV between 80 and 100 fL, and macrocytic, with an MCV larger than 100 fL. Now, let’s focus on the microcytic anemias, and the most common causes are iron deficiency anemia, lead poisoning, sideroblastic anemia, and thalassemias. Although microcytic anemia can also present in anemia of chronic disease, which is caused by Inflammatory conditions like rheumatoid arthritis, and systemic lupus erythematosus or SLE, it’s usually classified as normocytic anemia.

Now iron deficiency anemia, lead poisoning, and sideroblastic anemia are caused by defective heme synthesis, while thalassemias are caused by defective globin chains. Normally, RBCs are loaded with millions of copies of a protein called hemoglobin. Hemoglobin is actually made up of four peptide, or globin, chains, each bound to a heme group. Those 4 heme molecules have, right in the middle, iron, which binds to oxygen and allows it to move in our body.

Okay, so let’s look at iron deficiency anemia which could be caused by decreased intake, decreased absorption, increased demand, or increased loss of iron. For your exams, it’s important to know that the clues to help you identify this disorder are often based on the patient’s history. A high yield fact is that the most common cause of iron deficiency is chronic blood loss. This includes women with heavy menstruation or people with bleeding gastric ulcers, and, most importantly, elderly males with colon cancer that can bleed.

Another cause of iron deficiency is decreased absorption. The duodenal cells are normally responsible for the absorption of iron which is present in two forms in our diet, the heme iron and the non-heme iron. The heme iron is in the ferrous, or Fe2+ state and can be directly absorbed, but the non-heme iron is in the ferric, or Fe3+, state, and needs to be reduced to heme iron first before being absorbed. So the stomach’s hydrochloric acid activates a group of enzymes in the duodenal cells, collectively called ferri-reductase, which reduce Fe3+ to Fe2+. Okay, so decreased iron absorption can occur with inflammation and destruction of duodenal cells like in inflammatory bowel disease or celiac disease, or with decreased stomach acid production, like after a gastrectomy, where a part of the stomach is removed.

Next, malnutrition which sometimes happens in infants and vegans, and increased iron demand, like during pregnancy, can also cause iron deficiency anemia.

So whatever the cause, we end up with a decrease in the body’s iron stores, leading to decreased heme synthesis and normally, there’s a low level of free erythrocyte protoporphyrin, or FEP, in red blood cells since this is a precursor to heme. So when there’s a defect in heme synthesis, these precursors build up and it’s a good indicator for iron deficiency. The peripheral blood smear shows RBCs that are microcytic, since there’s not enough hemoglobin for a normal sized RBC, and the bone marrow starts pumping out smaller cells. They are also hypochromic since they contain less hemoglobin and look more pale. Okay, another important fact is that the red blood cell distribution width, or RDW, is high. This is because we get a mix of normal sized cells from before the iron deficiency and newly produced microcytic cells.

Okay, moving on. If someone is chronically exposed to lead, usually children ingesting lead-containing paint chips or adults who inhale lead while working in mines or industry, they can get lead poisoning.

Lead inhibits δ-aminolevulenic acid, or δ-ALA, dehydratase, and ferrochelatase, two important enzymes in the heme synthesis pathway. It’s important to remember that lead also inhibits rRNA degradation, causing old rRNA to accumulate inside the RBCs, forming tiny aggregates that are dispersed throughout the cytoplasm and this is referred to as stippling. Once again, this affects heme synthesis, so free erythrocyte protoporphyrin, or FEP, builds up. On a peripheral blood smear, these aggregates stain blue, so they are basophilic, and we call this basophilic stippling. Now, just like iron deficiency anemia there’s a decrease in hemoglobin synthesis so we get microcytic and hypochromic RBCs. The RDW is high, because we also get a mix of normal sized cells produced before the lead poisoning and newly produced microcytic cells.

Next up is sideroblastic anemia, where sidero means iron, and refers to iron accumulation in the mitochondria, and blast refers to the nucleated precursors of RBCs called erythroblasts. Sideroblastic anemia can be genetic or acquired. X-linked defect in ALA synthase gene is a genetic cause. ALA synthase normally catalyzes the first reaction in the heme biosynthetic pathway, and a defect in this enzyme prevents iron from being incorporated into heme and they build up in the mitochondria. The acquired causes include pyridoxine or vitamin B6 deficiency, since ALA synthase uses vitamin B6 as a cofactor. For your exams, vitamin B6 deficiency commonly occurs as a result of isoniazid, which binds and inactivates vitamin B6.

Myelodysplastic syndrome is an acquired cause of sideroblastic anemia where the blood forming cells in the bone marrow do not mature normally and become dysplastic. It’s important to know that this increases the risk of developing hematological malignancies like acute myeloid leukemia. Other acquired causes include chronic alcohol use, lead poisoning, vitamin B6 deficiency, copper deficiency, and drugs like isoniazid, and chloramphenicol. Remember for your test that these are reversible causes.

On a peripheral blood smear, we get microcytic hypochromic RBCs and basophilic stippling, so it’s similar to lead poisoning. However, the specific test to use is the prussian blue stain on a bone marrow biopsy specimen, which shows the iron laden mitochondria forming a ring around the nucleus, giving the classic ringed sideroblast appearance. Finally, the RDW is high as we get a mix of normal sized cells and newly produced microcytic cells.

Okay, moving on to thalassemias, where there’s a deficiency or absence in the production of the globin chains of hemoglobin. Hemoglobin A, or HbA, made up of two α-globin and two β-globin peptide chains, makes up approximately 97% of the total hemoglobin in adults. Hemoglobin A2, or HbA2, which is made up of two α-globin and two δ-globin chains makes up approximately 2.5% of total hemoglobin. Now, hemoglobin F, or HbF, made up of two α-globin and two γ-globin peptide chains, is the primary hemoglobin of the fetus, but makes up less than 1% in adults. In alpha-thalassemia, there is a mutation in the genes that code for alpha globin chains, while in beta-thalassemia, there is a mutation in the genes that code for the beta globin chains.

Sources

  1. "Robbins Basic Pathology" Elsevier (2017)
  2. "Harrison's Principles of Internal Medicine, Twentieth Edition (Vol.1 & Vol.2)" McGraw-Hill Education / Medical (2018)
  3. "Goldman-Cecil Medicine" Saunders (2015)
  4. "Letter to the Editor: Correcting iron deficiency" Australian Prescriber (2017)
  5. "Alpha-thalassemia" Genetics in Medicine (2011)
  6. "Iron deficiency anaemia" Lancet (2016)
  7. "Lead screening and prevalence of blood lead levels in children aged 1-2 years--Child Blood Lead Surveillance System, United States, 2002-2010 and National Health and Nutrition Examination Survey, United States, 1999-2010" MMWR Suppl. (2014)
  8. "Sideroblastic anemia: diagnosis and management" Hematol Oncol Clin North Am. (2014)